Prospective WSG phase III PlanB trial : Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer

Authors :: Gluz, O.
Nitz, U.
Christgen, M.
Kates, R.
Clemens, M.
Kraemer, S.
Nuding, B.
Aktas, B.
Kummel, S.
Reimer, T.
Lorenz-Salehi, F.
Krabisch, P.
Just, M.
Augustin, D.
Liedtke, C.
Svedman, C.
Shak, S.
Wurstlein, R.
Kreipe, H.
Harbeck, N.
Publication Year :: 2016

Tools